PTK2B/PYK2 Protein

PTK2B/PYK2 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PTK2B/PYK2 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">N-terminal FERM domain</td>
<td>1-400</td>
</tr>
<tr>
<td class="label">Proline-rich region 1</td>
<td>400-450</td>
</tr>
<tr>
<td class="label">Kinase domain</td>
<td>450-680</td>
</tr>
<tr>
<td class="label">Proline-rich region 2</td>
<td>680-750</td>
</tr>
<tr>
<td class="label">C-terminal focal adhesion targeting (FAT)</td>
<td>750-1009</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Src family kinases</td>
<td>Further signal amplification</td>
</tr>
<tr>
<td class="label">p130Cas</td>
<td>Cytoskeletal organization</td>
</tr>
<tr>
<td class="label">paxillin</td>
<td>Focal adhesion assembly</td>
</tr>
<tr>
<td class="label">ERK1/2</td>
<td>MAPK signaling</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Synaptic plasticity</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Peptide inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">Associated Di

PTK2B/PYK2 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PTK2B/PYK2 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">N-terminal FERM domain</td>
<td>1-400</td>
</tr>
<tr>
<td class="label">Proline-rich region 1</td>
<td>400-450</td>
</tr>
<tr>
<td class="label">Kinase domain</td>
<td>450-680</td>
</tr>
<tr>
<td class="label">Proline-rich region 2</td>
<td>680-750</td>
</tr>
<tr>
<td class="label">C-terminal focal adhesion targeting (FAT)</td>
<td>750-1009</td>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Src family kinases</td>
<td>Further signal amplification</td>
</tr>
<tr>
<td class="label">p130Cas</td>
<td>Cytoskeletal organization</td>
</tr>
<tr>
<td class="label">paxillin</td>
<td>Focal adhesion assembly</td>
</tr>
<tr>
<td class="label">ERK1/2</td>
<td>MAPK signaling</td>
</tr>
<tr>
<td class="label">PSD-95</td>
<td>Synaptic plasticity</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Small molecule inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Peptide inhibitors</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Experimental</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's disease</a>, <a href="/wiki/huntington's-disease" style="color:#ef9a9a">Huntington's disease</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">131 edges</a></td>
</tr>
</table>

Ptk2B Pyk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

PTK2B (Protein Tyrosine Kinase 2 Beta), also known as PYK2 (Proline-Rich Tyrosine Kinase 2), is a non-receptor tyrosine kinase that plays critical roles in cell signaling, synaptic plasticity, and cellular responses to various stimuli. PTK2B is widely expressed in the brain and is involved in numerous signaling pathways that regulate neuronal function, survival, and plasticity. Genetic variants in PTK2B have been associated with Alzheimer's disease risk.

Structure

PTK2B is a 115 kDa non-receptor tyrosine kinase:

Domain Architecture

Key Features

• Autophosphorylation sites: Y402 (major autophosphorylation site)
• SH2 binding sites: Multiple tyrosine phosphorylation sites
• Focal adhesion targeting: Localizes to focal adhesions

Molecular Function

Signaling Pathways

Key Substrates

Cellular Functions

PTK2B regulates:

• Cell migration: Cytoskeletal dynamics
• Synaptic plasticity: Activity-dependent modifications
• Gene transcription: MAPK activation
• Cell survival: Anti-apoptotic signaling
• Calcium signaling: Modulates Ca²⁺ responses

Expression Pattern

Brain Expression

• [Hippocampus](/brain-regions/hippocampus): CA1-CA3 pyramidal [neurons](/entities/neurons)
• Cerebral [cortex](/brain-regions/cortex): Layer 2-6 neurons
• Cerebellum: Purkinje cells
• Striatum: Medium spiny neurons
• Thalamus: Relay neurons
• Brainstem: Various nuclei

Cellular Localization

• Cytosol: Primary location
• Focal adhesions: Membrane-associated
• Postsynaptic densities: Synaptic compartments
• Nucleus: Some translocation

Role in Neurodegeneration

Alzheimer's Disease

• Genetic association: PTK2B variants increase AD risk
• Synaptic dysfunction: Implicated in synaptic plasticity deficits
• [Tau](/proteins/tau) pathology: Links to [tau](/proteins/tau) phosphorylation
• Amyloid effects: [Aβ](/proteins/amyloid-beta)-induced PTK2B activation
• Therapeutic target: PTK2B inhibitors under investigation

Parkinson's Disease

• Dopaminergic signaling: Modulates dopamine responses
• Cell survival: Neuroprotective signaling
• [Alpha-synuclein](/proteins/alpha-synuclein): May interact with aggregation pathways

Stroke/Ischemia

• Excitotoxic damage: Activated by glutamate toxicity
• Cell death: Mediates ischemic injury
• Therapeutic potential: PTK2B inhibitors for stroke

Other Conditions

• Epilepsy: Altered signaling
• Traumatic brain injury: Activated by injury

Therapeutic Implications

Current Approaches

Challenges

• Kinase selectivity: Developing selective inhibitors
• [BBB](/entities/blood-brain-barrier) penetration: Brain-penetrant compounds needed
• Therapeutic window: Balancing efficacy and toxicity

Animal Models

• Ptk2b knockout mice: Viable with subtle phenotypes
• Transgenic models: AD and stroke models
• Conditional knockouts: Neuron-specific deletion

Research Directions

• PTK2B in synaptic plasticity mechanisms
• Understanding PTK2B genetic variants in AD
• Developing brain-penetrant inhibitors
• PTK2B as biomarker

Key Publications

Background

The study of Ptk2B Pyk2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• PTK2B Gene
• Tyrosine Kinases
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Proteins Index](/proteins)

External Links

• [UniProt: PTK2B](https://www.uniprot.org/uniprot/Q14289)
• [NCBI Gene: PTK2B](https://www.ncbi.nlm.nih.gov/gene/5747)
• [GeneCards: PTK2B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTK2B)

References